VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Gomella Discusses Informed Patient Decisions

Leonard G. Gomella, MD
Published: Monday, Apr 16, 2012

Leonard G. Gomella, MD, Bernard W. Godwin Jr. professor of prostate cancer and chairman of the Department of Urology, director of Clinical Affairs, Jefferson Kimmel Cancer Center, explains the need for an informed discussion on the risks and benefits of treatment and screening for patients with prostate cancer.

Counseling patients on the risks and benefits of screening is widely accepted. However, the patient's role in the treatment decision is a new and separate area that is evolving rapidly.

Many men that are newly diagnosed with prostate cancer are now treated with active surveillance rather than an active therapy, such as prostatectomy or radiation therapy. It is important to advise patients that their individual cancer may not require an active therapy during the screening process. Providing this information earlier in the process helps manage expectations and the treatment decision later on.

Leonard G. Gomella, MD, Bernard W. Godwin Jr. professor of prostate cancer and chairman of the Department of Urology, director of Clinical Affairs, Jefferson Kimmel Cancer Center, explains the need for an informed discussion on the risks and benefits of treatment and screening for patients with prostate cancer.

Counseling patients on the risks and benefits of screening is widely accepted. However, the patient's role in the treatment decision is a new and separate area that is evolving rapidly.

Many men that are newly diagnosed with prostate cancer are now treated with active surveillance rather than an active therapy, such as prostatectomy or radiation therapy. It is important to advise patients that their individual cancer may not require an active therapy during the screening process. Providing this information earlier in the process helps manage expectations and the treatment decision later on.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x